id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-304562-5xh4p786	Tanabe, Naoya	Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia	2020-11-07		.txt	text/plain	667	52	57	Dupilumab is widely used as an important biologic 33 agent to control severe condition of asthma, eosinophilic chronic rhinosinusitis, 34 and atopic dermatitis. In the pandemic of severe acute respiratory 35 syndrome-coronavirus-2 (SARS-CoV-2) and its associated respiratory disease, clinical course is summarized in Figure 1 . On day12, chest 51 computed tomography (CT) showed bilateral peripheral-dominant ground glass 52 opacity (GGO) and consolidation ( Fig. 2A) , and because he had several risk 53 factors for severe COVID-19 including obesity and diabetes, he was transferred 54 to intensive care unit at our hospital and received oxygen therapy via face mask 55 (5-6 L/min). Then, mepolizumab Dupilumab is an essential biologic agent for severe type of asthma, 84 eosinophilic chronic rhinosinusitis, and atopic dermatitis. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway 155 epithelial cells Asthma 166 exacerbation associated with COVID-19 pneumonia	./cache/cord-304562-5xh4p786.txt	./txt/cord-304562-5xh4p786.txt